RZLT Rezolute, Inc.
Rezolute, Inc. (RZLT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: March 30, 2026 , by Evans Daron .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO | Buy | 10,000 | $2.85 | $28.5K | 414,462 | |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Buy | 28,000 | $1.70 | $47.6K | 308,352 | |
| Hogenhuis Wladimir | Director | Buy | 5,650 | $1.69 | $9.5K | 119,675 | |
| Evans Daron 3 fills | CFO | Buy | 45,000 | $1.77 | $79.6K | 415,900 | |
| Elam Nevan C | CEO | Buy | 32,000 | $1.59 | $50.9K | 641,119 | |
| Karnawat Sunil Ratilal 2 fills | Chief Commercial Officer | Buy | 12,100 | $1.62 | $19.6K | 71,542 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.